Clinical characteristics and predictors of adverse outcomes in children with acute rheumatic fever from a high-endemic region of Brazil - Report - MDSpire

Clinical characteristics and predictors of adverse outcomes in children with acute rheumatic fever from a high-endemic region of Brazil

  • By

  • Renata Fonseca Mendoza

  • Letícia Leão de Oliveira

  • Bernardo Fonseca Mendoza

  • Jose Luiz Padilha da Silva

  • Paulo Henrique M. Melo

  • José Augusto Almeida Barbosa

  • Géssica Silva Santana

  • Airandes Pinto

  • Ndate Fall

  • Andrea Beaton

  • Maria Carmo Pereira Nunes

  • June 10, 2026

  • 0 min

Share

Clinical Features and Risk Factors for Negative Outcomes in Pediatric Acute Rheumatic Fever

Overview

Revise to correctly state that the absence of fever is associated with lower risk of severe outcomes.

Background

Acute rheumatic fever (ARF) is a significant cause of cardiovascular morbidity in children, particularly in low- and middle-income countries. Identifying children at high risk for adverse outcomes is crucial for timely management and prevention of rheumatic heart disease (RHD). This study addresses the need for effective risk stratification tools in resource-limited settings.

Data Highlights

CharacteristicValue
Median Age9 years
Female Percentage46%
Carditis Prevalence76%
Moderate-to-Severe Carditis49%
Primary Outcome (Cardiac Surgery or Death)13%
C-statistic0.82

Key Findings

  • 76% of children presented with carditis, with 49% having moderate-to-severe involvement.
  • Absence of fever was associated with a lower risk of adverse outcomes (OR 0.14).
  • Higher ESR levels were linked to increased risk (OR 1.04 per mm/h).
  • Lower hematocrit levels were also predictive of adverse outcomes (OR 0.85).
  • The final predictive model demonstrated good discrimination with a C-statistic of 0.82.
  • Incorporating ESR improved risk prediction metrics significantly.

Clinical Implications

Healthcare providers should consider simple inflammatory and hematologic markers, such as ESR and hematocrit, in assessing pediatric ARF patients. Early identification of high-risk children can facilitate timely interventions to prevent progression to severe rheumatic heart disease.

Conclusion

The study underscores the importance of using readily available clinical markers to predict adverse outcomes in pediatric ARF, which can enhance risk stratification and management in endemic regions.

Related Resources & Content

  1. Open Forum Infectious Diseases, 2023 -- Epidemiology and Outcomes of Pediatric Fever in a Rural District of Southern Mozambique: 17 Years of Morbidity Surveillance
  2. Open Forum Infectious Diseases, 2023 -- Clinical Features and Mortality of Chronic Pulmonary Aspergillosis in Brazil: a Multicenter Cohort Study
  3. Clinical Rheumatology, 2020 -- Influence of Clinical and Psychological Factors on Depression Among Rheumatoid Arthritis Patients: A Comparative Analysis Between Germany and Brazil
  4. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease, 2024
  5. Clinical Guidance for Acute Rheumatic Fever | Group A Strep | CDC, 2025
  6. Clinical Rheumatology — Rheumatoid Arthritis in Latin America: Key Challenges to Address
  7. Global prevalence and sex differences in rheumatic heart disease: a systematic review and updated meta-analysis
  8. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease
  9. Clinical Guidance for Acute Rheumatic Fever | Group A Strep | CDC

Original Source(s)

Related Content